Perphenazine antipsychotic drug

Perphenazine antipsychotic drug

A624/0376 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 47.2MB

Downloadable file size: 611.6KB

Price image Pricing

Please login to use the price calculator


Caption: Perphenazine antipsychotic drug, molecular model. This drug, marketed as Trilafon, Triavil and Etrafon, is a common treatment for patients suffering from psychoses, including schizophrenia and manic phases of bipolar disorder. It blocks the receptors for the neurotransmitter dopamine. Although the relationship between psychoses and dopamine is not fully understood, it is thought that many symptoms are linked to an excess of dopamine. Consequently, blocking the receptors can reduce these symptoms. Atoms in this model are represented by coloured rods; carbon is light blue, hydrogen is white, nitrogen is dark blue, sulphur is yellow, chlorine is green, and oxygen is red.

Release details: Model release not required. Property release not required.

Keywords: antipsychotic, artwork, biochemical, biochemistry, biological, biology, bipolar disorder, blocker, chemical, chemistry, clinical, compound, compounds, computer artwork, dopamine antagonist, drug, etrafon, illustration, mania, manic, medical, medicine, molecular, molecular model, molecule, molecules, neuroleptic, one, perphenazine, pharmaceutical, pharmaceutics, pharmacological, pharmacology, psychosis, psychotic, rod, rods, schizophrenia, schizophrenic, single, structure, triavil, trilafon, tube, tubes

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.